Back to search

France· FR:60728597

GILENYA 0,5 mg, gélule

A medicinal product containing chlorhydrate de fingolimod, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGILENYA 0,5 mg, géluleATC—REGISTER NO.FR:60728597PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE FINGOLIMOD
Manufacturer
NOVARTIS EUROPHARM (IRLANDE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400941778537
    7 plaquettes thermoformées unidoses perforées PVC PVDC aluminium de 1 gélule
  • cip13
    3400941778766
    plaquettes thermoformées PVC PVDC aluminium de 28 gélules
    EUR 579.28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhydrate de fingolimod in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhydrate de fingolimod products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Areleptan, Chantico
  • Belgium · Fingolimod Ab, Fingolimod Eg
  • Bulgaria · Chantico, Inzolfi
  • Cyprus · Fingolimod Adelco, Fingolimod Remedica
  • Czechia · Areleptan, Bonaxon
  • Germany · Fingod, Fingolimod 123 Acurae Pharma
  • Denmark · Areleptan, Bonaxon
  • Estonia · Chantico, Efigalo
  • Spain · Fingolimod, Fingolimod Aurovitas
  • Finland · Fingolimod, Fingolimod Avansor
  • United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
  • Greece · Fingolimod Adelco, Fingolimod Medochemie
  • Croatia · Areleptan, Arlesias
  • Hungary · Bonaxon, Chantico
  • Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
  • Iceland · Fingolimod, Fingolimod Accord
  • Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
  • Liechtenstein · Fingolimod Accord, Fingolimod Mylan
  • Lithuania · Chantico, Efigalo
  • Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
  • Latvia · Bonaxon, Chantico
  • Malta · Fingolimod Denk, Fingolimod Remedica
  • Netherlands · Chantico, Fenoxa
  • Norway · Areleptan, Fingolimod Accord
  • Poland · Bonaxon, Chantico
  • Portugal · Bluesar, Fingolimod Bluefish
  • Romania · Fingolimod Dr. Reddys, Fingolimod Msn
  • Sweden · Areleptan, Fingolimod Amarox
  • Slovenia · Areleptan, Arlesias
  • Slovakia · Areleptan, Bonaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1ba33a4-6eae-4959-87fd-1ba5a65ceb3a
GET /v1/drugs/c1ba33a4-6eae-4959-87fd-1ba5a65ceb3a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60728597",
  "date_amm": "2011-03-17",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/11/677",
  "substance": "CHLORHYDRATE DE FINGOLIMOD",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about chlorhydrate de fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.